1. ZFP91 disturbs metabolic fitness and antitumor activity of tumor-infiltrating T cells
- Author
-
Qiang Zou, Zhengting Wang, Feixiang Wang, Aiting Wang, Zhilin Hu, Xiaoyan Yu, Youqiong Ye, Xiao-Lu Teng, Yuerong Zhang, and Rui Ding
- Subjects
Cytotoxicity, Immunologic ,T-Lymphocytes ,Ubiquitin-Protein Ligases ,medicine.medical_treatment ,T cell ,mTORC1 ,Mechanistic Target of Rapamycin Complex 1 ,Lymphocyte Activation ,Mice ,Lymphocytes, Tumor-Infiltrating ,Cancer immunotherapy ,Tumor Microenvironment ,medicine ,Animals ,Humans ,Protein Phosphatase 2 ,Tumor microenvironment ,Chemistry ,General Medicine ,Immunotherapy ,Protein phosphatase 2 ,Mice, Inbred C57BL ,Cytosol ,Metabolic pathway ,medicine.anatomical_structure ,Cancer research ,Colorectal Neoplasms ,Glycolysis ,Research Article - Abstract
Proper metabolic activities facilitate T cell expansion and antitumor function; however, the mechanisms underlying disruption of the T cell metabolic program and function in the tumor microenvironment (TME) remain elusive. Here, we show a zinc finger protein 91–governed (ZFP91-governed) mechanism that disrupts the metabolic pathway and antitumor activity of tumor-infiltrating T cells. Single-cell RNA-Seq revealed that impairments in T cell proliferation and activation correlated with ZFP91 in tissue samples from patients with colorectal cancer. T cell–specific deletion of Zfp91 in mice led to enhanced T cell proliferation and potentiated T cell antitumor function. Loss of ZFP91 increased mammalian target of rapamycin complex 1 (mTORC1) activity to drive T cell glycolysis. Mechanistically, T cell antigen receptor–dependent (TCR-dependent) ZFP91 cytosolic translocation promoted protein phosphatase 2A (PP2A) complex assembly, thereby restricting mTORC1-mediated metabolic reprogramming. Our results demonstrate that ZFP91 perturbs T cell metabolic and functional states in the TME and suggest that targeting ZFP91 may improve the efficacy of cancer immunotherapy.
- Published
- 2021
- Full Text
- View/download PDF